[HTML][HTML] Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma
The immune system is strongly linked to the maintenance of healthy bone. Inflammatory
cytokines, specifically, are crucial to skeletal homeostasis and any dysregulation can result …
cytokines, specifically, are crucial to skeletal homeostasis and any dysregulation can result …
[HTML][HTML] Overcoming proteasome inhibitor resistance in the immunotherapy era
Proteasome inhibitors (PIs) are a fascinating class of small molecules that disrupt protein
homeostasis and are highly efficacious in the blood cancer multiple myeloma. However, PIs …
homeostasis and are highly efficacious in the blood cancer multiple myeloma. However, PIs …
[HTML][HTML] MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines
K Uhr, WJC Prager-van der Smissen, AAJ Heine… - PLoS …, 2019 - journals.plos.org
MicroRNAs (miRNAs) regulate gene expression post-transcriptionally. In this way they might
influence whether a cell is sensitive or resistant to a certain drug. So far, only a limited …
influence whether a cell is sensitive or resistant to a certain drug. So far, only a limited …
What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg
T Alexa-Stratulat, M Pešić, AČ Gašparović… - Drug Resistance …, 2019 - Elsevier
Identification of multidrug (MDR) efflux transporters that belong to the ATP-Binding Cassette
(ABC) superfamily, represented an important breakthrough for understanding cancer …
(ABC) superfamily, represented an important breakthrough for understanding cancer …
[HTML][HTML] Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple …
A Natoni, ML Farrell, S Harris, C Falank… - …, 2020 - ncbi.nlm.nih.gov
Aberrant glycosylation resulting from altered expression of sialyltransferases, such as ST3 β-
galactoside α2-3-sialyltransferase 6, plays an important role in disease progression in …
galactoside α2-3-sialyltransferase 6, plays an important role in disease progression in …
[HTML][HTML] Bone marrow stroma-induced transcriptome and regulome signatures of multiple myeloma
Simple Summary The bone marrow (BM) microenvironment provides a protective sanctuary
for multiple myeloma (MM) against therapeutic agents. MM cells interact with BM stromal …
for multiple myeloma (MM) against therapeutic agents. MM cells interact with BM stromal …
DKK1 activates noncanonical NF-κB signaling via IL-6–induced CKAP4 receptor in multiple myeloma
X Li, J Wang, S Zhu, J Zheng, Y Xie, H Jiang… - Blood …, 2021 - ashpublications.org
Proteasome inhibitors, such as bortezomib (BTZ), represent the key elements in
chemotherapy regimens for multiple myeloma (MM), whereas acquired chemoresistance …
chemotherapy regimens for multiple myeloma (MM), whereas acquired chemoresistance …
[PDF][PDF] Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer
R Kunder, M Velyunskiy, SF Dunne, BK Cho… - Cell chemical …, 2022 - cell.com
Triple-negative breast cancer (TNBC) is the breast cancer subtype with the poorest clinical
outcome. The PIM family of kinases has emerged as a factor that is both overexpressed in …
outcome. The PIM family of kinases has emerged as a factor that is both overexpressed in …
[HTML][HTML] Proteasome inhibition is an effective treatment strategy for microsporidia infection in honey bees
EM Huntsman, RM Cho, HV Kogan… - Biomolecules, 2021 - mdpi.com
The microsporidia Nosema ceranae is an obligate intracellular parasite that causes honey
bee mortality and contributes to colony collapse. Fumagillin is presently the only …
bee mortality and contributes to colony collapse. Fumagillin is presently the only …
[HTML][HTML] Therapeutics to harness the immune microenvironment in multiple myeloma
JJ Ignatz-Hoover, JJ Driscoll - Cancer Drug Resistance, 2022 - ncbi.nlm.nih.gov
Multiple myeloma (MM) remains an incurable, genetically heterogeneous disease
characterized by the uncontrolled proliferation of transformed plasma cells nurtured within a …
characterized by the uncontrolled proliferation of transformed plasma cells nurtured within a …